A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis

Summary

The purpose of the study is to examine the safety and effectiveness of sirolimus treatment for people with systemic sclerosis. The investigators perform a multi-centre, double-blind pilot trial with sirolimus in SSc.The investigators evaluate the effectiveness and safeness of sirolimus for Systemic Sclerosis by randomized controlled study (sirolimus 2mg/d (N = 36) versus placebo group (N = 36)).

Timeline

Start

2018-06-01

Primary completion

2018-12-31

Completion

2019-06-30

Drugs

Indications